No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial

The objective of the study was to assess the safety and immunogenicity of mRNA-1273 COVID-19 booster vaccination when co-administered with an egg-based standard dose seasonal quadrivalent influenza vaccine (QIV). This was a phase 3, randomized, open-label study. Eligible adults aged ≥ 18 years were...

Description complète

Détails bibliographiques

Auteurs principaux:	Abdi Naficy, Adrienne Kuxhausen, Harry Seifert, Andrew Hastie, Brett Leav, Jacqueline Miller, Kate Anteyi, Agnes Mwakingwe-Omari
Format:	Artigo
Langue:	Inglês
Publié:	Taylor & Francis Group 2024-12-01
Collection:	Human Vaccines & Immunotherapeutics
Sujets:	Co-administration COVID-19 vaccine immunogenicity influenza vaccine mRNA-1273
Accès en ligne:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2327736
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!